FIRM FIXED PRICE

ALBA BIOSCIENCE, INC. - QUOTIENTBD BLOOD BANK TRANSFUSION REAGENTS

PIID: 36C25924N0257
Signed Date: Oct 29, 2025Effective Date: Jun 1, 2024End Date: Closed on May 31, 2025
Award $
$47K
Vendor
ALBA BIOSCIENCE, INC.
NAICS
325413
Signed Date
Oct 29, 2025

Key Details

Dollars Obligated
$47,270.87
Base & All Options
$-7,654.56
Awarding Sub-Agency
Department of Veterans Affairs
Product Service Code
6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Extent Competed
FULL AND OPEN COMPETITION
Place of Performance
CHICAGO, IL, 606071670, CD-IL-07

Description

QUOTIENTBD BLOOD BANK TRANSFUSION REAGENTS

Context & Analysis

On Oct 29, 2025, Department of Veterans Affairs obligated $47,270.87 to ALBA BIOSCIENCE, INC. for quotientbd blood bank transfusion reagents. The award is classified under NAICS 325413 — IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition. Performance is located in CHICAGO, IL.

Contractor Information

UEI: V6KNKL6BDHL7
CAGE Code: 5TXY0
Location: CHICAGO, IL

Stay Updated

Get notified about new opportunities matching your interests.

Related